BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND IKZF1, LyF-1, 10320, ENSG00000185811, Q13422, Hs_54452, hIk-1, ZNFN1A1, IKAROS AND Diagnosis
90 results:

  • 1. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
    Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
    Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.
    van Outersterp I; Boer JM; van de Ven C; Reichert CEJ; Boeree A; Kruisinga B; de Groot-Kruseman HA; Escherich G; Sijs-Szabo A; Rijneveld AW; den Boer ML
    Blood Adv; 2024 Apr; 8(8):1835-1845. PubMed ID: 38386975
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Suspicion of constitutional abnormality at diagnosis of childhood leukemia: Update of the leukemia committee of the French Society of Childhood Cancers].
    Strullu M; Cousin E; de Montgolfier S; Fenwarth L; Gachard N; Arnoux I; Duployez N; Girard S; Guilmatre A; Lafage M; Loosveld M; Petit A; Perrin L; Vial Y; Saultier P
    Bull Cancer; 2024 Mar; 111(3):291-309. PubMed ID: 38267311
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic leukemia in an Academic Clinical Laboratory.
    Hu Z; Kovach AE; Yellapantula V; Ostrow D; Doan A; Ji J; Schmidt RJ; Gu Z; Bhojwani D; Raca G
    J Mol Diagn; 2024 Jan; 26(1):49-60. PubMed ID: 37981088
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic Mutation Profiles of Patients with Acute Myeloid leukemia in Korea: a Single-Center Experience.
    Han E; Ryu S; Kim D; Koh EH; Byun JH; Lee DH
    Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948498
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genes of Predisposition to Childhood Beta-Cell Acute Lymphoblastic leukemia in the Kazakh Population.
    Svyatova G; Boranbayeva R; Berezina G; Manzhuova L; Murtazaliyeva A
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2653-2666. PubMed ID: 37642051
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [leukemia Genotype Analysis of Children with Acute Lymphoblastic leukemia in Yunnan Area].
    Shi SL; Kui LY; Xia SM; Zhou BL; Li RJ; Jiang HC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):980-984. PubMed ID: 37551465
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Improved Outcome for ALL by Prolonging Therapy for
    Pieters R; de Groot-Kruseman H; Fiocco M; Verwer F; Van Overveld M; Sonneveld E; van der Velden V; Beverloo HB; Bierings M; Dors N; de Haas V; Hoogerbrugge P; Van der Sluis I; Tissing W; Veening M; Boer J; Den Boer M
    J Clin Oncol; 2023 Sep; 41(25):4130-4142. PubMed ID: 37459571
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
    Faria C; Tzankov A
    Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group.
    Kirtek T; Chen W; Laczko D; Bagg A; Koduru P; Foucar K; Venable E; Nichols M; Rogers HJ; Tam W; Orazi A; Hsi ED; Hasserjian RP; Wang SA; Arber DA; Weinberg OK
    Leuk Res; 2023 Jul; 130():107309. PubMed ID: 37210875
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. 'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting.
    Gupta DG; Varma N; Sreedharanunni S; Abdulkadir SA; Naseem S; Sachdeva MUS; Binota J; Bose P; Malhotra P; Khadwal A; Varma S
    Br J Cancer; 2023 Jul; 129(1):143-152. PubMed ID: 37156894
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Optical Genome Mapping Reveals and Characterizes Recurrent Aberrations and New Fusion Genes in Adult ALL.
    Vieler LM; Nilius-Eliliwi V; Schroers R; Vangala DB; Nguyen HP; Gerding WM
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980958
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The prognostic significance of
    Wang J; Sun K; Chen WM; Wang X; Li LD; Hao Y; Xu N; Jiang H; Xu LP; Wang Y; Zhang XH; Huang XJ; Jiang Q; Qin YZ
    Leuk Lymphoma; 2023 Mar; 64(3):698-706. PubMed ID: 36642937
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Targeted Treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic leukemia.
    Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
    Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning.
    Eckardt JN; Röllig C; Metzeler K; Kramer M; Stasik S; Georgi JA; Heisig P; Spiekermann K; Krug U; Braess J; Görlich D; Sauerland CM; Woermann B; Herold T; Berdel WE; Hiddemann W; Kroschinsky F; Schetelig J; Platzbecker U; Müller-Tidow C; Sauer T; Serve H; Baldus C; Schäfer-Eckart K; Kaufmann M; Krause S; Hänel M; Schliemann C; Hanoun M; Thiede C; Bornhäuser M; Wendt K; Middeke JM
    Haematologica; 2023 Mar; 108(3):690-704. PubMed ID: 35708137
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies.
    Fukuhara S; Oshikawa-Kumade Y; Kogure Y; Shingaki S; Kariyazono H; Kikukawa Y; Koya J; Saito Y; Tabata M; Yoshifuji K; Mizuno K; Miyagi-Maeshima A; Matsushita H; Sugiyama M; Ogawa C; Inamoto Y; Fukuda T; Sugano M; Yamauchi N; Minami Y; Hirata M; Yoshida T; Kohno T; Kohsaka S; Mano H; Shiraishi Y; Ogawa S; Izutsu K; Kataoka K
    Cancer Sci; 2022 Aug; 113(8):2763-2777. PubMed ID: 35579198
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Aberrant ikzf1 gene as relapse predictor in standard-risk pediatric patients with B-cell precursor acute lymphoblastic leukaemia.
    Vshyukova VS; Krasko OV; Yanchanka DA; Meleshko AN
    Int J Lab Hematol; 2022 Aug; 44(4):769-776. PubMed ID: 35505470
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic significance of ikzf1 deletions and ikzf1
    Braun M; Pastorczak A; Sędek Ł; Taha J; Madzio J; Jatczak-Pawlik I; Wypyszczak K; Matysiak M; Derwich K; Lejman M; Kazanowska B; Szczepański T; Kowalczyk JR; Mlynarski W;
    Hematol Oncol; 2022 Aug; 40(3):430-441. PubMed ID: 35118711
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Philadelphia-like acute lymphoblastic leukemia: Characterization in a pediatric cohort in a referral center in Colombia.
    Linares Ballesteros A; Yunis LK; García J; Aponte N; Flechas J; Martinez C; Uribe G; Quintero E; Díaz A; Pardo C; Sarmiento IC; Contreras A; Yunis JJ
    Cancer Rep (Hoboken); 2022 May; 5(5):e1587. PubMed ID: 34787376
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. CRLF2 and ikzf1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways.
    Moreno Lorenzana D; Juárez Velázquez MDR; Reyes León A; Martínez Anaya D; Hernández Monterde A; Salas Labadía C; Navarrete Meneses MDP; Zapata Tarrés M; Juárez Villegas L; Jarquín Ramírez B; Cárdenas Cardós R; Herrera Almanza M; Paredes Aguilera R; Pérez Vera P
    J Pathol Clin Res; 2021 Jul; 7(4):410-421. PubMed ID: 33890726
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.